Sodium antimony gluconate, amphotericin, and myocardial damage

Lancet

Volumn 351, Issue 9120, 1998, Pages 1928-1929

  Thakur, C P ^a  

^a Uma Complex   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANTIMONY GLUCONATE;

CLINICAL ARTICLE; CONTROLLED STUDY; DRUG FATALITY; HEART ARREST; HEART ARRHYTHMIA; HEART MUSCLE INJURY; HUMAN; LEISHMANIASIS; PRIORITY JOURNAL; SHORT SURVEY; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION;

EID: 0032572391     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78612-8     Document Type: Article

References (5)

1. 1 Thakur CP, Sinha GP, Pandey AK. Comparison of regimens of amphotericin B deoxycholate in kala-azar. Ind J Med Res 1996; 103: 29-263.
2. 2 Jha TK, Giri YN, Singh TK, Jha S. Use of amphotericin B in drug resistant cases of visceral leishmaniasis in North Bihar, India. Am J Trop Med Hyg 1995; 52: 536-38.
3. 3 Utz JP. Amphotericin B toxicity: general side effect. Ann Intern Med 1994; 61: 335-40.
4. 4 Thakur CP. Correction of serum electrolytes imbalance prevents cardiac arrhythmia during amphotericin B administration. Natl Med J Ind 1995; 8: 13-14.
5. 5 De Monaco HJ, Govern B. Transient asystole associated with amphotericin B infusion. Drug Intell Pharm 1983; 17: 547-48.